• Medical_Professionals
• Medical_students
• Nurses

Dear Colleagues,

On behalf of the European Association for the Study of the Liver (EASL), we are delighted to welcome to Porto for the EASL Monothematic Conference on "Liver Fibrosis: the next goal of targeted therapy?".

More than 30 years of intense research activity on this topic have brought major advances in the understanding and the clinical management of the fibrogenic process common to most chronic liver diseases. There are however many aspects that certainly deserve further attention. Our  conference is dedicated to all the current key areas of research in liver fibrogenesis and will focus on a number of open issues requiring further scientific efforts. The role of genetic/epigenetic factors and of the immune system, and the reversibility of fibrosis and methodologies for the identification of more reliable targets for drug development will represent some of the hot topics to be covered.

Young scientists are particularly encouraged to participate and will have the opportunity to present their original results during a dedicated session. The format is intended to generate active interactions and discussion between basic scientists and clinicians, and to foster future collaborative efforts to better understand the pathogenesis of tissue fibrosis in chronic liver disease. Ultimately, to improve patient management.

We sincerely hope that you will enjoy our conference and have a great time in Porto.

With warm regards

EUR

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

Porto Palacio Congress Hotel & Spa

Av. da Boavista 1269 4100-130, 

Porto, Portugal

Submission Info

All abstract submitters will be notified by e-mail by 12 April 2016.

PUBLICATION

Accepted abstracts will be published online on the conference website 2 weeks prior to the conference as well as in an e-book.

COPYRIGHTS

By submitting an abstract to an EASL event you agree with the following statement: 

"I hereby assign to the European Association for the Study of the Liver (EASL) the copyrights to the abstract submitted to the EASL Monothematic Conference on : "Liver fibrosis: the next goal of targeted therapy?" (government authors not electing to transfer agree to assign an exclusive publishing and distribution license) and any supplemental tables, illustrations or other information submitted therewith that are intended for publication as part of the abstract in all forms and media (whether now known or hereafter developed), throughout the world, in all languages, for the full term of copyright, effective when and if the article is accepted for publication. This transfer includes the right to provide the abstract in electronic and online forms and systems."

EPOSTERS

All abstracts that have been accepted for ePoster presentations require that at least one author attends the conference to present the work, and answer questions. EASL will offer ePoster format for all poster presentations. Full instructions concerning the preparation and presentation will be provided in the acceptance e-mail to be sent on 12 April 2016.

EASL Contact Information

Address:

7 rue Daubin

1203 Geneva

Switzerland

Tel: +41 (0) 22 807 03 60

Fax: +41 (0) 22 328 07 24

Email: easloffice@easloffice.eu

EASL Contact Information

Address:

7 rue Daubin

1203 Geneva

Switzerland

Tel: +41 (0) 22 807 03 60

Fax: +41 (0) 22 328 07 24

Email: easloffice@easloffice.eu